Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
Oumayma Mnafe, Clinical Hematology Resident at Faculty of Medicine, Pharmacy and Dental Medicine of Fez, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Cureus Journal of Medical Science, adding:
“Pleased to share our latest publication about Clinical Profile of Venous Thromboembolism and Applicability of the ThroLy and IMPEDE VTE Risk Scores in Patients With Lymphoma and Multiple Myeloma.
A Moroccan Single-Center Retrospective Study.”
Title: Clinical Profile of Venous Thromboembolism and Applicability of the ThroLy and IMPEDE VTE Risk Scores in Patients With Lymphoma and Multiple Myeloma: A Moroccan Single-Center Retrospective Study
Authors: Oumayma Mnafe, Asmae Jamlaoui, Hicham Eddou
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 9, 2026, 13:17Andrew Zapfel: Building a Stronger Future for Sickle Cell Care in Kenya
-
Aug 9, 2026, 13:07Angelica Varesi: New Insights into Hematopoietic Stem Cell Biology
-
Aug 9, 2026, 12:48Paul Watton։ New Clues to the Cause of ME/CFS
-
Aug 9, 2026, 12:26Mohamed Rawy: When Is a Reduced DOAC Dose Appropriate?
-
Aug 9, 2026, 11:22Saqib Ullah: Why Do Red Blood Cells Autoagglutinate
-
Aug 9, 2026, 10:06Care Shouldn’t Depend on Where You Live – National Bleeding Disorders Foundation
-
Aug 9, 2026, 10:01Irma Bagdoniene: Plaque Stability and the Importance of LDL Lowering
-
Aug 9, 2026, 09:49Rana Al-Dhalaan: New Study Examines Viral Infections in Blood Donors
-
Aug 9, 2026, 09:29Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk